Transcriptomic profiling of Schlemm's canal cells reveals a lymphatic-biased identity and three major cell states.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
18 Oct 2024
Historique:
medline: 18 10 2024
pubmed: 18 10 2024
entrez: 18 10 2024
Statut: epublish

Résumé

Schlemm's canal (SC) is central in intraocular pressure regulation but requires much characterization. It has distinct inner and outer walls, each composed of Schlemm's canal endothelial cells (SECs) with different morphologies and functions. Recent transcriptomic studies of the anterior segment added important knowledge, but were limited in power by SEC numbers or did not focus on SC. To gain a more comprehensive understanding of SC biology, we performed bulk RNA sequencing on C57BL/6 J SC, blood vessel, and lymphatic endothelial cells from limbal tissue (~4,500 SECs). We also analyzed mouse limbal tissues by single-cell and single-nucleus RNA sequencing (C57BL/6 J and 129/Sj strains), successfully sequencing 903 individual SECs. Together, these datasets confirm that SC has molecular characteristics of both blood and lymphatic endothelia with a lymphatic phenotype predominating. SECs are enriched in pathways that regulate cell-cell junction formation pointing to the importance of junctions in determining SC fluid permeability. Importantly, and for the first time, our analyses characterize three molecular classes of SECs, molecularly distinguishing inner wall from outer wall SECs and discovering two inner wall cell states that likely result from local environmental differences. Further, and based on ligand and receptor expression patterns, we document key interactions between SECs and cells of the adjacent trabecular meshwork (TM) drainage tissue. Also, we present cell type expression for a collection of human glaucoma genes. These data provide a new molecular foundation that will enable the functional dissection of key homeostatic processes mediated by SECs as well as the development of new glaucoma therapeutics.

Identifiants

pubmed: 39422453
doi: 10.7554/eLife.96459
pii: 96459
doi:
pii:

Banques de données

GEO
['GSE272434', 'GSE271132', 'GSE168200']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : BrightFocus Foundation
ID : CG2020004
Organisme : BrightFocus Foundation
ID : G2021007S
Organisme : NEI NIH HHS
ID : R01EY028175
Pays : United States
Organisme : NEI NIH HHS
ID : R01EY032507
Pays : United States
Organisme : NEI NIH HHS
ID : R01EY032062
Pays : United States
Organisme : NEI NIH HHS
ID : R01EY029548
Pays : United States
Organisme : NEI NIH HHS
ID : R01EY022359
Pays : United States
Organisme : New York Fund for Innovation in Research and Scientific Talent
ID : EMPIRE CU19-2660

Informations de copyright

© 2024, Balasubramanian, Kizhatil et al.

Déclaration de conflit d'intérêts

RB, KK, TL, NT, AB, GC, VB, RK, SZ, JP, MS, CM, WS, JQ, SJ No competing interests declared

Auteurs

Revathi Balasubramanian (R)

Department of Ophthalmology, Columbia University Irving Medical Center, New York, United States.

Krishnakumar Kizhatil (K)

Department of Ophthalmology and Visual Sciences, The Ohio State University Medical Center, Columbus, United States.

Taibo Li (T)

Department of Molecular Biology and Genetics, Johns Hopkins University, Baltimore, United States.

Nicholas Tolman (N)

Department of Ophthalmology, Columbia University Irving Medical Center, New York, United States.
Graduate School of Biomedical Sciences, Tufts University School of Medicine, Boston, United States.

Aakriti Bhandari (A)

Department of Ophthalmology, Columbia University Irving Medical Center, New York, United States.
Neuroscience Graduate Program, University of Utah, Salt Lake City, United States.

Graham Clark (G)

Department of Ophthalmology and Visual Sciences, The Ohio State University Medical Center, Columbus, United States.

Violet Bupp-Chickering (V)

Department of Ophthalmology, Columbia University Irving Medical Center, New York, United States.

Ruth A Kelly (RA)

Department of Ophthalmology, Duke University, Durham, United States.

Sally Zhou (S)

Department of Ophthalmology, Columbia University Irving Medical Center, New York, United States.
SUNY Downstate Health Sciences University, New York, United States.

John Peregrin (J)

Department of Ophthalmology, Columbia University Irving Medical Center, New York, United States.

Marina Simón (M)

Department of Ophthalmology, Columbia University Irving Medical Center, New York, United States.

Christa Montgomery (C)

Department of Ophthalmology, Columbia University Irving Medical Center, New York, United States.

W Daniel Stamer (WD)

Department of Ophthalmology, Duke University, Durham, United States.

Jiang Qian (J)

Department of Ophthalmology, Johns Hopkins School of Medicine, Baltimore, United States.

Simon W M John (SWM)

Zuckerman Mind Brain Behavior Institute, Columbia University, New York, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH